There was no significant difference in hBD-1 levels before (499.35 ± 199.11) and after (419.73 ± 250.78) the phase I periodontal therapy in patients with periodontitis (P = 0.389, by ANOVA). The gene discussed is DEFB1; the disease is periodontitis.